Treatment and Survival of Elderly Patients with Stage I-II Pancreatic Cancer: A Report of the EURECCA Pancreas Consortium.

Jesse Vincent GroenTom A DouwesElizabeth van EyckenLydia G M van der GeestTom B JohannesenMarc G BesselinkBas Groot KoerkampJohanna W WilminkBert A BonsingJohanna E A PortieljeCornelus J H van de VeldeEsther BastiaannetJ Sven D Mieognull null

Published in: Annals of surgical oncology (2020)

Differences were observed in treatment and OS in patients aged ≥ 70 years with stage I-II pancreatic cancer, between the population-based cancer registries. Future studies should focus on selection criteria for (non)surgical treatment in older patients so that clinicians can tailor treatment.

Keyphrases

end stage renal disease
newly diagnosed
squamous cell carcinoma
chronic kidney disease
prognostic factors
peritoneal dialysis
current status
replacement therapy
patient reported outcomes
lymph node metastasis
squamous cell